{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:17:10Z","timestamp":1783808230960,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Zambon"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.tips.2019.04.015","type":"journal-article","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T16:16:35Z","timestamp":1558973795000},"page":"452-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics"],"prefix":"10.1016","volume":"40","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2019.04.015_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001287.pub2","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.04.015_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007168.pub3","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","author":"Tam","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.04.015_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007168.pub2","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","author":"Nash","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.04.015_bb0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/15412555.2017.1347918","article-title":"Impact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysis","volume":"14","author":"Cazzola","year":"2017","journal-title":"COPD"},{"key":"10.1016\/j.tips.2019.04.015_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pupt.2017.11.009","article-title":"Impact of erdosteine on chronic bronchitis and COPD: a meta-analysis","volume":"48","author":"Cazzola","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tips.2019.04.015_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/rccm.201802-0245OC","article-title":"An improved inhaled mucolytic to treat airway muco-obstructive diseases","volume":"199","author":"Ehre","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0040","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/17476348.2018.1495562","article-title":"Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease","volume":"12","author":"Calzetta","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0045","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1183\/09031936.94.07091622","article-title":"Stimulation of Cl\u2212 secretion by the mucoactive drug S-carboxymethylcysteine-lysine salt in the isolated rabbit trachea","volume":"7","author":"Colombo","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.tips.2019.04.015_bb0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/COPD.S3735","article-title":"The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease","volume":"3","author":"Hooper","year":"2008","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.tips.2019.04.015_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pupt.2018.10.005","article-title":"Erdosteine: drug exhibiting polypharmacy for the treatment of respiratory diseases","volume":"53","author":"Dal Negro","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12931-016-0500-y","article-title":"Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation","volume":"18","author":"Cazzola","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.tips.2019.04.015_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.rmed.2016.06.015","article-title":"The effect of N-acetylcysteine on biofilms: implications for the treatment of respiratory tract infections","volume":"117","author":"Blasi","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0070","first-page":"344","article-title":"Effects of erdosteine and its metabolites on bacterial adhesiveness","volume":"49","author":"Braga","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tips.2019.04.015_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.bcp.2012.05.005","article-title":"Role of NADPH oxidase\/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases","volume":"84","author":"Lee","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2019.04.015_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/17476348.2016.1121105","article-title":"Oxidation pathway and exacerbations in COPD: the role of NAC","volume":"10","author":"Matera","year":"2016","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cotox.2017.09.001","article-title":"Oxidative stress in the lung \u2013 the essential paradox","volume":"7","author":"Rogers","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.tips.2019.04.015_bb0095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0076-6879(05)01028-1","article-title":"Gamma-glutamyl transpeptidase in glutathione biosynthesis","volume":"401","author":"Zhang","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.tips.2019.04.015_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bcp.2010.10.001","article-title":"Targeting maladaptive glutathione responses in lung disease","volume":"81","author":"Gould","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2019.04.015_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chembiol.2018.01.011","article-title":"N-acetyl cysteine functions as a fast-acting antioxidant by triggering intracellular H2S and sulfane sulfur production","volume":"25","author":"Ezeri\u0146a","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tips.2019.04.015_bb0110","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1139\/v89-190","article-title":"Kinetic study of the oxidation mechanism of glutathione by hydrogen peroxide in neutral aqueous medium","volume":"67","author":"Abedinzadeh","year":"1989","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.tips.2019.04.015_bb0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0891-5849(02)00791-8","article-title":"Electron paramagnetic resonance spin trapping investigation into the kinetics of glutathione oxidation by the superoxide radical: re-evaluation of the rate constant","volume":"32","author":"Jones","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2018.04.011","article-title":"N-acetylcysteine protects human bronchi by modulating the release of neurokinin A in an ex vivo model of COPD exacerbation","volume":"103","author":"Calzetta","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2019.04.015_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thx.46.1.39","article-title":"Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine","volume":"46","author":"Bridgeman","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.tips.2019.04.015_bb0130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/rmed.2001.1066","article-title":"Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease","volume":"95","author":"Kasielskim","year":"2001","journal-title":"Respir. Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0135","first-page":"700","article-title":"Protective effect of erdosteine metabolite I against hydrogen peroxide-induced oxidative DNA-damage in lung epithelial cells","volume":"61","author":"Marabini","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tips.2019.04.015_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11010-006-0640-3","article-title":"Effects of erdosteine on bleomycin-induced lung fibrosis in rats","volume":"281","author":"Boyaci","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tips.2019.04.015_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jat.1133","article-title":"Comparison of the effects of erdosteine and N-acetylcysteine on apoptosis regulation in endotoxin-induced acute lung injury","volume":"26","author":"Demiralay","year":"2006","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tips.2019.04.015_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1440-1843.2008.01424.x","article-title":"Carbocisteine can scavenge reactive oxygen species in vitro","volume":"14","author":"Nogawa","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.tips.2019.04.015_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2004.10.007","article-title":"Exhaled interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys)","volume":"505","author":"Carpagnano","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2019.04.015_bb0160","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1042\/BST0391268","article-title":"Thiol regulation of pro-inflammatory cytokines and innate immunity: protein S-thiolation as a novel molecular mechanism","volume":"39","author":"Coppo","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tips.2019.04.015_bb0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","article-title":"Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review","volume":"20","author":"Sadowska","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0014-5793(00)01464-2","article-title":"N-acetylcysteine suppresses TNF-induced NF-\u03baB activation through inhibition of I\u03baB kinases","volume":"472","author":"Oka","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2019.04.015_bb0175","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2019.04.015_bb0180","first-page":"325","article-title":"Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells","volume":"57","author":"Radomska-Le\u015bniewska","year":"2006","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.tips.2019.04.015_bb0185","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.93.01090832","article-title":"Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables","volume":"1","author":"Eklund","year":"1988","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.tips.2019.04.015_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/PL00000203","article-title":"Induced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factors","volume":"49","author":"van Overveld","year":"2000","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.tips.2019.04.015_bb0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1734-1140(10)70250-4","article-title":"N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients","volume":"62","author":"Radomska-Le\u015bniewska","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.tips.2019.04.015_bb0200","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2019.04.015_bb0205","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/resp.12592","article-title":"Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial","volume":"20","author":"Alfonso","year":"2015","journal-title":"Respirology"},{"key":"10.1016\/j.tips.2019.04.015_bb0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/resp.12662","article-title":"Systemic inflammation and oxidative stress post-lung resection: effect of pretreatment with N-acetylcysteine","volume":"21","author":"Bastin","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.tips.2019.04.015_bb0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000094379","article-title":"Effect of metabolite I of erdosteine on the release of human neutrophil elastase","volume":"77","author":"Braga","year":"2006","journal-title":"Pharmacology"},{"key":"10.1016\/j.tips.2019.04.015_bb0220","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1165\/rcmb.2012-0292OC","article-title":"Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke","volume":"50","author":"Yageta","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.tips.2019.04.015_bb0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.intimp.2014.12.018","article-title":"Carbocisteine attenuates hydrogen peroxide-induced inflammatory injury in A549 cells via NF-\u03baB and ERK1\/2 MAPK pathways","volume":"24","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tips.2019.04.015_bb0230","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/aps.2015.150","article-title":"Carbocisteine attenuates TNF-\u03b1-induced inflammation in human alveolar epithelial cells in vitro through suppressing NF-\u03baB and ERK1\/2 MAPK signaling pathways","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tips.2019.04.015_bb0235","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00128-18","article-title":"Reduce, induce, thrive: bacterial redox sensing during pathogenesis","volume":"200","author":"Reniere","year":"2018","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.tips.2019.04.015_bb0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00268-003-7402-0","article-title":"Development of a wound dressing targeting neutrophil function","volume":"28","author":"Nygren","year":"2004","journal-title":"World J. Surg."},{"key":"10.1016\/j.tips.2019.04.015_bb0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/jcm.5.1.58-61.1977","article-title":"Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro","volume":"5","author":"Parry","year":"1977","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.tips.2019.04.015_bb0250","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnx087","article-title":"Effects of N-acetyl-L-cysteine on the membrane vesicle release and growth of respiratory pathogens","volume":"364","author":"Volgers","year":"2017","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.tips.2019.04.015_bb0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12866-016-0872-7","article-title":"N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions","volume":"16","author":"Amaral","year":"2016","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.tips.2019.04.015_bb0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/7171_2006_060","article-title":"Cysteine metabolism and its regulation in bacteria","volume":"5","author":"Gu\u00e9don","year":"2006","journal-title":"Microbiol. Monogr."},{"key":"10.1016\/j.tips.2019.04.015_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/03602532.2011.631015","article-title":"S-carboxymethyl-L-cysteine","volume":"44","author":"Mitchell","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tips.2019.04.015_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1601-1546.2004.00112.x","article-title":"Biofilms in endodontic infections","volume":"9","author":"Svens\u00e4ter","year":"2004","journal-title":"Endod. Top."},{"key":"10.1016\/j.tips.2019.04.015_bb0275","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AEM.69.8.4814-4822.2003","article-title":"N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces","volume":"69","author":"Olofsson","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.tips.2019.04.015_bb0280","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1038\/s41598-017-05178-3","article-title":"Mechanistic action of weak acid drugs on biofilms","volume":"7","author":"Kundukad","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2019.04.015_bb0285","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1159\/000487566","article-title":"The interaction of N-acetylcysteine and serum transferrin promotes bacterial biofilm formation","volume":"45","author":"Yin","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tips.2019.04.015_bb0290","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/thx.43.8.585","article-title":"Influence of erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis","volume":"43","author":"Ricevuti","year":"1988","journal-title":"Thorax"},{"key":"10.1016\/j.tips.2019.04.015_bb0295","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000063223","article-title":"Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone","volume":"47","author":"Braga","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.tips.2019.04.015_bb0300","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1128\/AAC.01334-16","article-title":"Effect of high N-acetylcysteine concentrations on antibiotic activity against a large collection of respiratory pathogens","volume":"60","author":"Landini","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2019.04.015_bb0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diagmicrobio.2010.03.016","article-title":"Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetylcysteine, amoxicillin, erythromycin, and levofloxacin","volume":"67","author":"del Prado","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.tips.2019.04.015_bb0310","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.micinf.2017.08.008","article-title":"The role of oxidative stress in influenza virus infection","volume":"19","author":"Liu","year":"2017","journal-title":"Microbes Infect."},{"key":"10.1016\/j.tips.2019.04.015_bb0315","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1152\/ajplung.00376.2009","article-title":"Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells","volume":"299","author":"Yamaya","year":"2010","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.tips.2019.04.015_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.resp.2013.10.010","article-title":"Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg\/day NAC in moderate to severe COPD patients: a pilot study","volume":"191","author":"Sinojia","year":"2014","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.tips.2019.04.015_bb0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/13543784.11.1.15","article-title":"Mucoactive drugs for asthma and COPD: any place in therapy?","volume":"11","author":"Rogers","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.tips.2019.04.015_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001287.pub5","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2019.04.015_bb0335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pupt.2006.03.011","article-title":"Increased hydrogen peroxide concentration in the exhaled breath condensate of stable COPD patients after nebulized N-acetylcysteine","volume":"20","author":"Rysz","year":"2007","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.resinv.2015.11.004","article-title":"Effect of inhaled N-acetylcysteine monotherapy on lung function and redox balance in idiopathic pulmonary fibrosis","volume":"54","author":"Muramatsu","year":"2016","journal-title":"Respir. Investig."},{"key":"10.1016\/j.tips.2019.04.015_bb0345","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00711-2017","article-title":"Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study","volume":"50","author":"Dal Negro","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.tips.2019.04.015_bb0350","first-page":"277","article-title":"Antioxidants and chronic obstructive pulmonary disease","volume":"5","author":"V\u00e9zina","year":"2018","journal-title":"Chronic. Obstr. Pulm. Dis."},{"key":"10.1016\/j.tips.2019.04.015_bb0355","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1401739","article-title":"Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis","volume":"370","author":"Martinez","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0360","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.pupt.2005.02.001","article-title":"Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine","volume":"18","author":"Yildirim","year":"2005","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0365","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2016.07.009","article-title":"Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"40","author":"Rogliani","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0370","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"TOLLIP, MUC5B, and the response to N-acetylcysteine among Individuals with idiopathic pulmonary fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0375","first-page":"103","article-title":"Effects of N-acetylcysteine on asthma exacerbation","volume":"9","author":"Aliyali","year":"2010","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.tips.2019.04.015_bb0380","first-page":"184","article-title":"Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma","volume":"12","author":"Eftekhari","year":"2013","journal-title":"EXCLI J."},{"key":"10.1016\/j.tips.2019.04.015_bb0385","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4104\/pcrj.2011.00007","article-title":"Primary care summary of the British Thoracic Society guideline on the management of non-cystic fibrosis bronchiectasis","volume":"20","author":"Hill","year":"2011","journal-title":"Prim. Care Respir. J."},{"key":"10.1016\/j.tips.2019.04.015_bb0390","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/039463201302600228","article-title":"Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children","volume":"26","author":"Snijders","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.tips.2019.04.015_bb0395","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbres.2017.07.016","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.tips.2019.04.015_bb0400","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.clinthera.2007.09.003","article-title":"Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study","volume":"29","author":"Crisafulli","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tips.2019.04.015_bb0405","first-page":"113","article-title":"Cystic fibrosis: myths, mistakes, and dogma","volume":"15","author":"Rubin","year":"2014","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.tips.2019.04.015_bb0410","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cbi.2010.04.021","article-title":"Effect of thiol drugs on tert-butyl hydroperoxide induced luminol chemiluminescence in human erythrocytes, erythrocyte lysate, and erythrocyte membranes","volume":"186","author":"Sajewicz","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2019.04.015_bb0415","series-title":"Coronary Artery Disease","first-page":"95","article-title":"The role of oxidative stress","author":"Tsalamandris","year":"2018"},{"key":"10.1016\/j.tips.2019.04.015_bb0420","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tips.2019.04.015_bb0425","first-page":"141","article-title":"Glutathione as a marker for human disease","volume":"Vol. 87","author":"Teskey","year":"2018"},{"key":"10.1016\/j.tips.2019.04.015_bb0430","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tips.2019.04.015_bb0435","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1080\/17476348.2016.1240032","article-title":"Clinical approach to the diagnosis and treatment of cystic fibrosis and CFTR-related disorders","volume":"10","author":"Michl","year":"2016","journal-title":"Expert Rev. Respir. Med."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719300926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614719300926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:08:34Z","timestamp":1759050514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614719300926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":87,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0165614719300926"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2019.04.015","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2019.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}